RESEARCH BRIEFS: Depression among RA patients

February 2004
GP: General Practitioner;2/2/2004, p11
More than six out of 10 people with rheumatoid arthritis (RA) have suffered from depression, according to a report from the National Rheumatoid Arthritis Society. Almost eight out of 10 agreed that daily pain of RA was the major reason.


Related Articles

  • Depression, inflammation, and pain in patients with rheumatoid arthritis.  // International Journal of Advances in Rheumatology;2009, Vol. 7 Issue 4, p126 

    Pain is a common symptom in rheumatoid arthritis (RA) patients. In this cross-sectional study, independent influences of depression and C-reactive protein levels were observed on perceived pain. Although this study shows only associations, it is the first that provides evidence that an optimal...

  • Monoarticular septic arthritis in a patient with juvenile rheumatoid arthritis under etanercept treatment. Lin, Kai-Cheng; Liang, Chi-Di; Yang, Kuender; Yu, Hong-Ren; Kuo, Ho-Chang // Rheumatology International;May2012, Vol. 32 Issue 5, p1383 

    A 7-year-old girl with polyarticular type juvenile rheumatoid arthritis (JRA) presented with acute onset of right hip pain with limited range of motion and fever within the past two days. She had received etanercept for more than one year. Percutaneous arthrocentesis was performed and showed a...

  • Editorials: Sulphasalazine in rheumatoid arthritis: an old drug revived. Neumann, V. C.; Grindulis, K. A. // Journal of the Royal Society of Medicine;Mar1984, Vol. 77 Issue 3, p169 

    The article discusses the benefits of sulphasalazine in treating rheumatoid arthritis. Sulphasalazine is an old drug which is a compound of sulphapyridine and 5-aminosalicylic acid linked by an azo bond. The benefits of salicylates in rheumatoid arthritis have an excellent effect on the...

  • Osteoarthritis. Bernstein, Ian // Pulse;Jun2014, p88 

    The article presents questions and answers related to osteoarthritis (OA) including one on diagnosis for OA, difference between rheumatoid arthritis and OA, and non-pharmacological measures to treat OA.

  • Fibromyalgic rheumatoid arthritis and disease assessment. Pollard, Louise C.; Kingsley, Gabrielle H.; Choy, Ernest H.; Scott, David L. // Rheumatology;May2010, Vol. 49 Issue 5, p924 

    Objective. We evaluated fibromyalgic RA to determine its clinical impact, identification using core clinical assessments and influence identifying active disease using disease activity scores (DAS-28).

  • Adalimumab for Rheumatoid Arthritis? Ebell, Mark; Kripke, Clarissa // American Family Physician;2/1/2006, Vol. 73 Issue 3, p435 

    Answers a question on the safety and effectiveness of adalimumab (Humira) for rheumatoid arthritis. Required dosage of adalimumab; Effectiveness of the combination of adalimumab with methotrexate; Indications for adalimumab.

  • White cells count in smokers affected by rheumatic diseases. Bartolone, Sebastiano; Calzavara, Emilse; Russo, Giuseppina; Carnì, Antonio; Mannucci, Carmen; Pieratti, Antonella; Caputi, Achille; Calapai, Gioacchino // Rheumatology International;Jan2012, Vol. 32 Issue 1, p109 

    Evidence shows that tobacco smoking interacts with development of rheumatic diseases. Increase in white cells count (leukocytosis) is frequently present, and in smokers, it is considered a biomarker of cardiovascular risk. Aim of the study is to evaluate this biomarker in smokers with rheumatic...

  • Wie wirksam ist Rituximab bei der rheumatoiden Arthritis? Schmidt, W. A.; Schicke, B.; Krause, A.; Wernicke, D. // Zeitschrift für Rheumatologie;Jun2010, Vol. 69 Issue 4, p349 

    Does experience with rituximab treatment of rheumatoid arthritis (RA) in daily clinical practice confirm the results of controlled randomized studies? This is a retrospective data-analysis of the first 50 patients from one center with rituximab treatment for RA. The patients received at least...

  • The effect of low-dose prednisone on bone mineral density in Peruvian rheumatoid arthritis patients. Chung, Cecilia P.; Russell, Anthony S.; Segami, Maria I.; Ugarte, César A. // Rheumatology International;Mar2005, Vol. 25 Issue 2, p114 

    Objective: The aim of this study was to determine the difference between bone mineral density (BMD) of rheumatoid arthritis (RA) patients on low-dose prednisone and matched RA patients without prior systemic corticosteroid therapy. Methods: Ninety patients attending our clinics and receiving 10...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics